Home/ Supplements/ Vitamin K/ Vitamin K-2 100 mcg MK-7

Vitamin K-2 100 mcg MK-7

product on market Tablet or Pill Superior Source Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin K2 as MK-7 is supported by moderate evidence for promoting calcium homeostasis and supporting bone and cardiovascular health. Stevia leaf extract serves as a non-nutritive sweetener with a well-established safety profile. Overall, the evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K-2 100 mcg MK-7
Open Full PDF View on NIH DSLD →
Details

Label Data

1 MicroLingual(R) Tablet(s)
Serving Size
60
Servings
Botanical with Nutrients
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg (125% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)
Stevia leaf extract
1 mg

Other Ingredients

Lactose Calcium Phosphate Acacia Gum
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Place on or under the tongue

Directions: As a dietary supplement, dissolve one MicroLingual tablet under the tongue daily. This product may also be chewed/swallowed.

Warnings & Precautions

Warnings: If your are currently taking any anti-coagulant drugs (warfarin, coumadin, heparin, i.e.) or if you are pregnant/lactating, consult your healthcare provider before taking this product.

Keep out of reach of children.

Formulation Notes

GMO and preservative free

Additional Information

"Less is more" Simplicity Purity Efficiency No pills to swallow

Dissolves on contact

Chewing leads to smooth and better absorption Tablet color, taste and texture may vary slightly from batch to batch. Potency is not affected by these natural variances Please read all label information

Made in USA

GMO free

Our proprietary hydrodrying process results in fewer inactive binders and fillers and a higher ratio of nutritional ingredients - hence the small size. They efficiently provide your body with the nutrients you need right now.

Metadata

Product Details

DSLD Entry Date2017-02-24
Product TypeBotanical with Nutrients
FormTablet or Pill
DSLD ID70865
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.